Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment
Open Access
- 3 June 2022
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-15
Abstract
Background: In the absence of clinical trials, data on the safety of medicine exposures in pregnancy are dependent on observational studies conducted after the agent has been licensed for use. This requires an accurate history of antenatal medicine use to determine potential risks. Medication use is commonly determined by self-report, clinician records, and electronic pharmacy data; different data sources may be more informative for different types of medication and resources may differ by setting. We compared three methods to determine antenatal medicine use (self-report, clinician records and electronic pharmacy dispensing records [EDR]) in women attending antenatal care at a primary care facility in Cape Town, South Africa in a setting with high HIV prevalence. Methods: Structured, interview-administered questionnaires recorded self-reported medicine use. Data were collected from clinician records and EDR on the same participants. We determined agreement between these data sources using Cohen’s kappa and, lacking a gold standard, used Latent Class Analysis to estimate sensitivity, specificity and positive predictive value (PPV) for each data source. Results: Between 55% and 89% of 967 women had any medicine use documented depending on the data source (median number of medicines/participant = 5 [IQR 3–6]). Agreement between the datasets was poor regardless of class except for antiretroviral therapy (ART; kappa 0.6–0.71). Overall, agreement was better between the EDR and self-report than with either dataset and the clinician records. Sensitivity and PPV were higher for self-report and the EDR and were similar for the two. Self-report was the best source for over-the-counter, traditional and complementary medicines; clinician records for vaccines and supplements; and EDR for chronic medicines. Conclusions: Medicine use in pregnancy was common and no single data source included all the medicines used. ART was the most consistently reported across all three datasets but otherwise agreement between them was poor and dependent on class. Using a single data collection method will under-estimate medicine use in pregnancy and the choice of data source should be guided by the class of the agents being investigated.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD080465)
- National Institute of Allergy and Infectious Diseases (U01AI069911)
This publication has 30 references indexed in Scilit:
- Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platformBMC Pregnancy and Childbirth, 2014
- Latent Class Models in Diagnostic Studies When There is No Reference Standard--A Systematic ReviewAmerican Journal of Epidemiology, 2013
- Investigating outcomes associated with medication use during pregnancy: A review of methodological challenges and observational study designsReproductive Toxicology, 2012
- Determinants of self medication practices among pregnant women in Ibadan, NigeriaInternational Journal of Clinical Pharmacy, 2011
- Prescription drug use during pregnancy in developed countries: a systematic reviewPharmacoepidemiology and Drug Safety, 2011
- Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth RegisterClinical Epidemiology, 2011
- Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription DatabasePharmacoepidemiology and Drug Safety, 2010
- Prescription drugs among pregnant women in Lome, Togo, West AfricaEuropean Journal of Clinical Pharmacology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic groupJournal of Clinical Epidemiology, 2008